Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Alphabet Inc. (GOOG, GOOGL)

Q3 2023 · 13F-HR

Alphabet Inc. (GOOG, GOOGL)holdings as filed

Filed 2023-11-13 · accession 0001652044-23-000098

$1.56B
Reported value
45
Positions
2023-09-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
90364P105PATHUIPATH INC$240.7M15.5%14,068,674CommonSHARED
22788C105CRWDCROWDSTRIKE HLDGS INC$214.9M13.8%1,283,683CommonSHARED
92539P101VERVE THERAPEUTICS INC$139.9M8.98%10,549,086CommonSHARED
37637K108GTLBGITLAB INC$119.7M7.69%2,647,312CommonSHARED
74168J101PRMEPRIME MEDICINE INC$113.2M7.27%11,862,498CommonSHARED
26886C107EQRX INC$105.8M6.80%47,675,476CommonSHARED
042068205ARMARM HOLDINGS PLC$104.9M6.74%1,960,784CommonSHARED
72703X106PLPLANET LABS PBC$83.1M5.33%31,942,641CommonSHARED
833445109SNOWSNOWFLAKE INC$81.8M5.26%535,604CommonSHARED
687793109OSCROSCAR HEALTH INC$80.6M5.18%14,477,374CommonSHARED
358054104FRSHFRESHWORKS INC$80.4M5.16%4,035,595CommonSHARED
252131107DXCMDEXCOM INC$61.1M3.92%654,854CommonSHARED
25058X105DESKTOP METAL INC$16.1M1.04%11,048,730CommonSHARED
75943R102RLAYRELAY THERAPEUTICS INC$13.2M0.85%1,568,753CommonSHARED
799566104SANASANA BIOTECHNOLOGY INC$10.9M0.70%2,812,500CommonSHARED
00534A102IVVDINVIVYD INC$9.7M0.62%5,680,785CommonSHARED
75382E109RAPT THERAPEUTICS INC$9.0M0.58%540,270CommonSHARED
55083R104LYELL IMMUNOPHARMA INC$8.6M0.55%5,865,125CommonSHARED
07373V105BEAMBEAM THERAPEUTICS INC$7.7M0.50%321,604CommonSHARED
452327109ILMNILLUMINA INC$7.3M0.47%53,470CommonSHARED
61225M102GLUEMONTE ROSA THERAPEUTICS INC$7.0M0.45%1,464,015CommonSHARED
082490103BENSON HILL INC$5.1M0.33%15,352,271CommonSHARED
91864C107BRNSVACCITECH PLC$4.7M0.30%1,513,644CommonSHARED
92337R101VERAVERA THERAPEUTICS INC$4.1M0.27%301,580CommonSHARED
252828108DNTHDIANTHUS THERAPEUTICS INC$2.9M0.18%208,697CommonSHARED
640979100NMRANEUMORA THERAPEUTICS INC.$2.8M0.18%199,608CommonSHARED
89854M101TCRXTSCAN THERAPEUTICS INC$2.8M0.18%1,077,080CommonSHARED
344174107FHTXFOGHORN THERAPEUTICS INC$2.5M0.16%500,901CommonSHARED
87990A106TNYATENAYA THERAPEUTICS INC$2.3M0.15%915,705CommonSHARED
877619106TSHATAYSHA GENE THERAPIES INC$2.0M0.13%640,882CommonSHARED
50107A104KRON1USDKRONOS BIO INC$1.9M0.12%1,438,232CommonSHARED
44916K106HYPRHYPERFINE INC$1.8M0.12%898,720CommonSHARED
05280R100AUTLAUTOLUS THERAPEUTICS PLC$1.6M0.10%698,262CommonSHARED
30063P105EXKEXACT SCIENCES CORP$1.6M0.10%23,205CommonSHARED
808644108SCIENCE 37 HOLDINGS INC$1.3M0.08%3,207,260CommonSHARED
014442107ALECALECTOR INC$1.1M0.07%175,866CommonSHARED
84833T103SPROSPERO THERAPEUTICS INC$1.1M0.07%889,979CommonSHARED
753018100RANIRANI THERAPEUTICS HLDGS INC$973,2270.06%448,492CommonSHARED
22053A107QUINCE THERAPEUTICS INC$211,8170.01%189,122CommonSHARED
299734202EVLOEVELO BIOSCIENCES INC$207,8540.01%53,024CommonSHARED
46185L103NVTA1EURINVITAE CORP$143,7200.01%235,606CommonSHARED
465712107MONDMONDEE HOLDINGS INC$65,7590.00%18,420CommonSHARED
359616109FULCFULCRUM THERAPEUTICS INC$63,3230.00%14,262CommonSHARED
759916109RGENREPLIGEN CORP$60,9010.00%383CommonSHARED
229790100HLTHQCUE HEALTH INC$11,8800.00%27,000CommonSHARED

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.